Related Experiment Video
Updated: Sep 10, 2025

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3
Published on: January 24, 2016
Alternatively spliced isoforms of IRF7 differentially regulate interferon expression to tune response to viral
Asmita Panthi1, Max B Ferretti2, Olivia Howard2
1Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Pharmacology Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Abstract:
Interferon regulatory factor 7 (IRF7) is a master transcriptional regulator of innate immunity. IRF7 binds as a homodimer, or heterodimer with IRF3, to promoters of type I interferons (IFN-Is) to drive their expression, which activates expression of antiviral genes. Here, we demonstrate that alternative splicing of the first intron within the coding region of human IRF7 is regulated across immune tissues and in response to immunologic stimuli. Retention of this intron generates an alternative translation start site, resulting in an N-terminally extended form of the protein (exIRF7) compared to the canonical isoform (cIRF7). We find that exIRF7 has increased dimerization relative to cIRF7, uniquely activates expression of IFN-Is in response to double-stranded RNA (dsRNA) sensing, and controls viral infection to a greater extent than cIRF7. Thus, alternative splicing of IRF7 is a previously unrecognized mechanism by which human cells tune IRF7 function and the IFN response to control immune challenge.
More Related Videos
Related Concept Videos
Regulation of the Unfolded Protein Response
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi
RNA Splicing
Leaky Scanning

